About the research we take part in
- 1,180 participants recruited into research studies in 2021/22
- 72 trials open across 21 specialities
- 51 investigators leading the delivery of trials
- Two of our own chief investigators leading trust initiated trials
Our contribution to COVID research
COVID-19 research studies are still taking place across the hospital – including in the emergency department, infectious diseases, respiratory medicine, critical care, maternity care and paediatrics. These aim to improve our understanding of the disease and find effective treatments.
Over the past two years we have contributed data and information from more than 3,442 participants into 16 COVID-19 trials.
A total of 925 patients were recruited into the Recovery COVID-19 treatment trial, which was the first trial to identify effective treatments for COVID-19. We were the second highest recruiting hospital to this trial in terms of the percentage of patients admitted that were recruited.
Data from 922 patients has been submitted for analysis to the CCP ISARIC trial, which was a national database of information on all patients admitted with COVID to try to understand risk factors and effective management.
A total of 534 participants were recruited into the Novavax COVID-19 vaccine trial. The trial was delivered jointly by all three DTVRA trusts buy our medics, research staff and volunteers. An incredible testament to our collaboration with our neighbouring trusts.
Areas of research activity
We try to ensure we have research trials in all of our clinical areas to ensure all patients have access to cutting edge treatments.
In 2021/22 we ran research trials in the following clinical areas:
- Anaesthesia, perioperative medicine and pain
- Cancer
- Cardiovascular disease
- Children
- Critical care
- Dementia and neurodegenerative disorders
- Dermatology
- Diabetes
- Gastroenterology
- Haematology
- Health services research
- Hepatology
- Infection
- Mental health
- Musculoskeletal disorders
- Stroke
- Surgery
- Trauma and emergency medicine
National studies where we are a top recruiting site
- Recovery: COVID-19 treatment study – second top recruiter in the country
- SNAP3: Obs and Gynae smoking cessation study – second top recruiter in the country
- BHF SENIOR-RITA: Cardiac Myocardial Infarction treatment study – top UK recruiter
- CONSCOP2: GI Endoscopy contrast enhancement study – consistently one of the top four recruiting sites in the country
Performance in initiating and delivering clinical research (PID)
The Government’s Plan for Growth, published in March 2011, announced the transformation of incentives at local level for efficiency in initiation and delivery of research and wishes to see a dramatic and sustained improvement in the performance of providers of NHS services.
The aim is to increase the number of patients who have the opportunity to participate in research and to enhance the nation’s attractiveness as a host for research.
NHS providers holding National Institute of Health Research (NIHR) contracts are required to provide, on a quarterly basis, information on recruitment to clinical trials, including commercial trials.
The overall aim is increasing the number of patients able to participate in research, and enhancing the nation’s attractiveness as a host for research.
The trust must submit information in two areas to the Central Commissioning Facility (CCF) within 30 days of the end of each quarter and make the information publicly available.
Latest performance initiating and delivery reports